Proteostasis Therapeutics
Why Robinhood?
You can watch PTI and buy or sell other stocks, ETFs, and their options commission-free!About PTI
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb.
PTI Key Statistics
Stock Snapshot
Proteostasis Therapeutics(PTI) stock is priced at $1.89, giving the company a market capitalization of 4.55M. It carries a P/E multiple of -0.50.
On 2026-07-13, Proteostasis Therapeutics(PTI) stock opened at —, reached a high of —, and a low of —.
Proteostasis Therapeutics(PTI) shares are trading with a volume of 0, against a daily average of 15.46K.
During the past year, Proteostasis Therapeutics(PTI) stock moved between $0.18 at its lowest and $1.15 at its peak.
During the past year, Proteostasis Therapeutics(PTI) stock moved between $0.18 at its lowest and $1.15 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.